查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2017547

獸用驅蟲藥市場：依動物種類、寄生蟲種類、產品類型、給藥途徑及通路分類－2026-2032年全球市場預測

Animal Parasiticides Market by Animal Type, Parasite Type, Product Type, Route Of Administration, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，獸醫寄生蟲控制市場價值將達到 152.2 億美元，到 2026 年將成長至 164.6 億美元，到 2032 年將達到 297.8 億美元，複合年成長率為 10.06%。

主要市場統計數據
基準年 2025 152.2億美元
預計年份：2026年 164.6億美元
預測年份 2032 297.8億美元
複合年成長率 (%) 10.06%

簡明策略介紹，概述獸用驅蟲藥市場的整體情況，明確主要相關人員、治療領域和短期優先事項。

本次實施為重點研究獸用寄生蟲控制劑奠定了基礎，明確了相關人員的業務領域以及影響短期決策的實際問題。研究範圍涵蓋伴侶動物和牲畜產品，包括體外和體內寄生蟲的治療方法。這些產品透過多種給藥途徑，包括注射、口服和外用，並透過各種分銷管道送達最終用戶。了解這些方面對於企業主管至關重要，因為他們必須調整產品開發平臺、監管合規計畫和經營模式，以適應不斷變化的臨床需求和客戶期望。

對正在深刻改變動物驅蟲產業的關鍵科學、商業性、監管和供應鏈趨勢進行前瞻性概述。

在科學創新、不斷變化的消費者行為以及重新定義競爭優勢的系統性政策調整的驅動下，該領域正經歷變革性的轉變。製劑科學和標靶驅蟲化學的突破使得藥物作用持續時間更長、給藥更精準，而診斷工具和農場數據分析的進步則使寄生蟲監測更加切實可行。同時，伴侶動物健康管理中的數位化管道和服務（例如遠端醫療）正在改變診療路徑，並增加了對便利性、速效產品和訂閱模式的需求。這些技術和商業性趨勢與對合理使用抗菌藥物和驅蟲藥的日益重視相交織，迫使產品開發人員在其研發流程和適應症使用指南中考慮抗藥性風險。

對美國 2025 年新的關稅調整將如何重塑供應鏈、籌資策略和商業化重點進行策略性評估。

美國2025年實施的新關稅和調整後的貿易政策對整個驅蟲藥供應鏈產生了深遠的營運和戰略影響。依賴全球採購的藥用活性成分和特殊添加劑的製造商立即面臨採購成本上升的壓力，迫使他們重新評估供應商基礎和合約條款。為此，一些公司加快了供應商多元化進程，並將部分生產流程在地化，以降低關稅風險。另一些公司則自行承擔了增加的成本，或調整了利潤率管理策略，以保持對通路敏感的買家的價格競爭力。

綜合細分分析揭示了動物種類、寄生蟲種類、產品類型、給藥途徑和分銷管道如何影響策略選擇。

市場區隔提供了一種分析觀點，揭示了治療需求、營運要求和商業性機會之間的交集。依動物種類分析，突顯了伴侶動物和牲畜分銷管道在使用者行為、劑型和給藥途徑偏好方面的差異。伴侶動物市場傾向於選擇以便利性為優先的局部用藥和口服製劑，而牲畜應用則更側重於注射劑和大規模分銷。根據寄生蟲類型，體外寄生蟲和體內寄生蟲之間的差異會影響產品製劑設計和合理使用的考量。例如，體外寄生蟲控制劑需要具有長效接觸或全身作用的特性來控制跳蚤、蜱蟲、蝨子和蟎蟲，而體內寄生蟲控制劑則針對具有不同藥物動力學要求的體內寄生蟲和原生動物病原體。

對影響世界各地商業和營運策略的需求促進因素、監管複雜性和分銷方面的細微差異進行區域分析。

區域趨勢對監管預期、消費者行為以及產品整個生命週期的物流可行性有顯著影響。在美洲，獸醫診所的整合、寵物需求的成長以及先進的零售藥局管道為高階配方和訂閱服務創造了機會。同時，農業生產系統需要擴充性且穩健的解決方案，以適應集約化農業實踐。在歐洲、中東和非洲，監管協調的努力與各國不同的政策和區域獸醫基礎設施並存，因此需要製定本地化的監管策略並與當地相關人員進行溝通。在全部區域，管理和殘留物管理仍然是重中之重。

簡要概述影響動物寄生蟲控制領域成功的競爭格局、創新路徑、夥伴關係模式和能力投資。

獸醫寄生蟲防治領域的競爭動態由創新開發商、老牌製藥公司、非專利生產商和專業經銷商共同塑造。創新領導企業投資於新型化學製劑、長效製劑和配套診斷，以建構差異化的產品組合；而非專利企業則在製劑效率和規模方面展開競爭，以滿足價格敏感型市場的需求。經銷商和獸醫網路在產品訊息和分銷中發揮著至關重要的作用，與獸醫的關係會影響處方和用藥模式。

提出切實可行的策略和營運建議，使研究、採購、管理和通路策略與當前產業需求保持一致。

產業領導者應採取果斷行動，使研發、採購和商業性執行與該領域不斷變化的挑戰保持一致。首先，他們應優先考慮關鍵活性成分和添加劑供應商網路的多元化，以降低關稅和市場集中風險，並在經濟可行的情況下建立合格的國內或區域製造商。其次，他們應將診斷和合理用藥推廣工具融入產品價值提案，確保功效聲明有數據驅動的使用指導和耐受性降低計劃的支持。第三，他們應採用針對不同管道的商業化模式，例如線上藥局、零售藥局和藥局以及獸醫院和診所。這可能包括為伴侶動物提供訂閱服務或為畜牧養殖戶提供服務包。

對主要和次要調查方法、相關人員參與、細分邏輯和品質保證措施進行透明的解釋，以確保分析的嚴謹性。

本報告的調查方法結合了與關鍵相關人員的對話、對第二手資料的系統性回顧以及嚴謹的檢驗，以確保其可靠性。主要資訊是透過對執業獸醫、農場管理者、監管專家以及產品開發和分銷領域的企業領導者進行結構化訪談收集的。這些定性對話旨在揭示實際的限制因素、現實世界的應用趨勢以及針對政策和供應鏈變化的策略性應對措施。二手資料經過仔細審查，以了解技術進步、監管變化和臨床指南的背景，重點關注同行評審的文獻和監管出版刊物。

簡要概述了應對不斷變化的抗寄生蟲產品市場格局所需的策略挑戰、營運重點和能力投資。

總之，動物農藥產業正處於轉折點，由於科學進步、客戶期望變化、監管趨嚴以及貿易政策趨勢等因素的共同作用，其策略重點正在重新定義。那些能夠將差異化治療特性與務實的管理、穩健的籌資策略以及充分考慮銷售管道的商業化模式相結合的公司，將更有利於獲取永續價值。伴侶動物發展趨勢與畜牧生產需求之間的相互作用，既帶來了機遇，也帶來了營運上的複雜性，因此需要謹慎地進行優先排序和投資。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：動物驅蟲市場：依動物類型分類

  • 伴侶動物
  • 家畜

第9章：以寄生蟲類型分類的動物驅蟲市場

  • 體外寄生蟲
  • 體內寄生蟲

第10章：動物驅蟲藥市場：依產品類型分類

  • 體外寄生蟲控制劑
    • 跳蚤和蜱蟲產品
    • 治療蝨子的產品
    • 除蟎產品
  • 體內寄生蟲控制劑
    • 殺蟲劑
    • 原生動物驅蟲藥

第11章：獸用驅蟲藥市場：依給藥途徑分類

  • 注射藥物
  • 口服
  • 外用

第12章：動物驅蟲藥市場：依通路分類

  • 網路藥房
  • 藥局和藥局
  • 獸醫醫院和診所

第13章：動物驅蟲藥市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：獸用驅蟲藥市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：各國動物驅蟲藥市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國動物殺蟲劑市場

第17章：中國動物殺蟲劑市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Bimeda Animal Health Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva SA
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Idexx Laboratories Inc.
  • Merck & Co., Inc.
  • PetIQ, Inc.
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-031BF22F9497

The Animal Parasiticides Market was valued at USD 15.22 billion in 2025 and is projected to grow to USD 16.46 billion in 2026, with a CAGR of 10.06%, reaching USD 29.78 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 15.22 billion
Estimated Year [2026] USD 16.46 billion
Forecast Year [2032] USD 29.78 billion
CAGR (%) 10.06%

A concise strategic introduction framing the animal parasiticides landscape, defining core stakeholders, therapeutic categories, and near-term priorities

This introduction establishes the context for a focused exploration of animal parasiticides, clarifying the arena in which stakeholders operate and the practical themes that shape near-term decisions. The subject spans products intended for both companion animals and livestock and encompasses therapeutic approaches aimed at external and internal parasites, delivered via injectable, oral, and topical routes, and routed to end users through a spectrum of distribution channels. Understanding these dimensions is essential for executives who must align development pipelines, regulatory plans, and commercial models with evolving clinical needs and customer expectations.

The landscape is influenced by converging drivers: accelerating pet ownership and humanization of companion animals, intensified production demands in livestock systems, and heightened regulatory and stewardship expectations around resistance management and residue safety. These pressures are matched by technological advances across diagnostics, formulation science, and data-enabled service models that are reshaping how interventions are developed and delivered. In consequence, companies that combine therapeutic innovation with pragmatic supply-chain resilience and customer-centric distribution strategies are positioned to navigate the shifting environment more effectively.

A forward-looking synthesis of the major scientific, commercial, regulatory, and supply-chain forces dramatically reshaping the animal parasiticides sector

The sector is undergoing transformative shifts driven by scientific innovation, evolving customer behavior, and systemic policy change that together redefine competitive advantage. Breakthroughs in formulation science and targeted anthelmintic chemistries are enabling longer durations of efficacy and more precise dosing, while advances in diagnostic tools and on-farm data analytics are making parasite surveillance more actionable. Concurrently, digital channels and telemedicine-like services for companion animal health are altering care pathways, increasing demand for convenient, fast-acting products and subscription-based models. These technical and commercial dynamics are intersecting with stronger emphasis on antimicrobial and antiparasitic stewardship, prompting product developers to account for resistance risk in R&D pipelines and in-label usage guidance.

Supply-chain modernization and sustainability expectations are also reshaping supplier relationships and procurement strategies. Manufacturers are increasingly assessing supplier concentration risks, raw-material provenance, and the environmental footprint of both active ingredients and delivery systems. Regulatory agencies are tightening safety and residue standards in many jurisdictions, thereby increasing the importance of robust clinical programs and post-market surveillance. As a result, successful players will be those that integrate scientific differentiation with disciplined stewardship, resilient sourcing, and distribution models that respond to both professional veterinary settings and consumer-facing channels.

A strategic review of how new United States tariff adjustments in twenty twenty five are reshaping supply chains, sourcing strategies, and commercialization priorities

The introduction of new tariffs and adjusted trade policies in the United States during 2025 has produced a range of operational and strategic effects across the parasiticides supply chain. Manufacturers that rely on globally sourced active pharmaceutical ingredients and specialty excipients experienced immediate procurement cost pressure and were prompted to reevaluate supplier footprints and contractual terms. In response, some firms accelerated supplier diversification and localized certain manufacturing steps to mitigate tariff exposure, while others absorbed cost increases or redirected margin management initiatives to preserve pricing competitiveness against channel-sensitive buyers.

Distribution players and veterinary service providers likewise adjusted inventory strategies and contract negotiations to manage increased import-related volatility. The cumulative effect extended beyond unit economics to influence product development prioritization, with some organizations deferring noncritical launches and others prioritizing lower-cost formulation platforms that reduce reliance on tariff-exposed imports. In addition, the policy change amplified the strategic value of digital direct-to-consumer channels and domestic contract manufacturing, as these routes offered alternate ways to preserve market access and service continuity amid cross-border tariff friction.

An integrated segmentation analysis that reveals how animal type, parasite class, product categories, administration routes, and distribution channels influence strategic choices

Segmentation provides the analytical lens that reveals where therapeutic demand intersects with operational requirements and commercial opportunity. When analyzed by animal type, differences between companion animal and livestock channels surface in user behavior, dosing formats, and route-of-administration preferences; companion animal markets often favor convenience-focused topical and oral solutions while livestock applications emphasize injectable formats and large-volume logistics. Based on parasite type, the distinction between external parasites and internal parasites informs product formulation and stewardship considerations, as ectoparasiticides require long-acting contact or systemic profiles to control fleas, ticks, lice, and mites whereas endoparasiticides target internal helminths and protozoal pathogens with different pharmacokinetic demands.

Based on product type, the broad categories of ectoparasiticides and endoparasiticides each contain sub-classes that drive distinct development pathways: ectoparasiticides include flea and tick products, lice products, and mite products that must balance rapid knockdown with residual activity, while endoparasiticides encompass anthelmintics and antiprotozoals that must meet efficacy, safety, and withdrawal criteria for food animals. Based on route of administration, injectable, oral, and topical options present trade-offs in adherence, dosing accuracy, and veterinary supervision requirements. Based on distribution channel, channel dynamics vary among online pharmacies, traditional pharmacies and drug stores, and veterinary hospitals and clinics, with each channel presenting unique regulatory constraints, margin structures, and customer relationships that shape go-to-market approaches.

A regional read on demand drivers, regulatory complexity, and distribution nuances shaping commercial and operational strategies across global territories

Regional dynamics materially influence regulatory expectations, customer behavior, and logistical feasibility across the product lifecycle. In the Americas, veterinary practice consolidation, strong companion animal demand, and advanced retail pharmacy channels create opportunities for premium formulations and subscription-based services, while production agriculture systems demand scalable, robust solutions that align with intensive husbandry practices. In Europe, Middle East & Africa, regulatory harmonization efforts coexist with diverse national policies and variable veterinary infrastructure, requiring tailored regulatory strategies and localized stakeholder engagement; stewardship and residue management remain high priorities across this geography.

Asia-Pacific features rapidly growing companion animal ownership in urban centers and continued intensification of livestock production, resulting in rising demand for both retail-oriented products and high-throughput farm solutions. This region also presents complex supply-chain considerations, including local manufacturing capabilities, differing regulatory timelines, and varying levels of veterinary professionalization. Taken together, regional variation underscores the need for companies to deploy modular strategies that balance global platform investments with region-specific commercialization and regulatory approaches.

A concise overview of competitive structures, innovation pathways, partnership models, and capability investments that determine success in animal parasiticides

Competitive dynamics in the animal parasiticides arena are shaped by a mix of innovative developers, established pharmaceutical manufacturers, generic producers, and specialized distributors. Innovation leaders are investing in novel chemistries, long-acting formulations, and companion diagnostics to build differentiated franchises, while generic players compete on formulation efficiency and scale to serve price-sensitive segments. Distributors and veterinary networks play a pivotal role in stewardship messaging and product adoption, and their relationships with practitioners influence prescribing and usage patterns.

Collaborative models are increasingly prevalent: strategic alliances, co-development agreements, and contract manufacturing partnerships enable faster route-to-market and lower capital intensity for late-stage development programs. Corporate strategies also include selective acquisitions aimed at filling capability gaps in formulation science, biologicals, or digital services, as well as investments in in-house manufacturing to secure supply-chain control. Overall, success is increasingly determined by the ability to combine technical differentiation with pragmatic commercialization capabilities and trusted stakeholder relationships across practitioner and farmer communities.

Actionable strategic and operational recommendations that align research, sourcing, stewardship, and channel strategies to current industry imperatives

Industry leaders should act decisively to align R&D, sourcing, and commercial execution with the sector's evolving imperatives. First, prioritize diversification of supplier networks for critical active ingredients and excipients to reduce tariff and concentration exposure while establishing qualified domestic or regional manufacturers where economically viable. Second, integrate diagnostic and stewardship tools into product value propositions so that efficacy narratives are supported by data-driven use guidance and resistance mitigation plans. Third, adopt channel-specific commercialization models that reflect the differing needs of online pharmacies, retail pharmacies and drug stores, and veterinary hospitals and clinics; this may include subscription services for companion animals and service bundles for livestock producers.

Additionally, invest in regulatory intelligence and proactive engagement with authorities to anticipate labeling and residue requirements, and build scenario-based supply-chain planning into annual operational reviews. Embrace sustainability metrics in product and packaging decisions to meet customer and regulatory expectations and to protect long-term license to operate. Finally, pursue targeted collaborations-whether with diagnostics companies, digital service providers, or contract manufacturers-to accelerate access to capability gaps without unduly increasing fixed costs.

A transparent explanation of primary and secondary research methods, stakeholder engagement, segmentation logic, and quality-assurance measures that ensure analytical rigor

The research methodology underpinning the report combines primary stakeholder engagement with systematic secondary evidence review and rigorous triangulation to ensure reliability. Primary inputs were gathered through structured interviews with practicing veterinarians, farm managers, regulatory specialists, and commercial leaders across product development and distribution. These qualitative engagements were designed to surface practical constraints, real-world adoption behaviors, and strategic responses to policy and supply-chain shifts. Secondary sources were reviewed to contextualize technological advances, regulatory changes, and clinical guidance, with attention paid to peer-reviewed literature and regulatory agency publications.

Analytical rigor was maintained through cross-validation of qualitative insights against documented regulatory actions and publicly available technical literature. Segmentation was developed to reflect clinically meaningful distinctions-animal type, parasite type, product class, route of administration, and distribution channel-and was applied consistently across regional assessments. The methodology acknowledges limitations inherent in qualitative research, including potential respondent bias, and mitigates these through sample diversity, source triangulation, and transparent documentation of data provenance.

A succinct closing synthesis that distills strategic imperatives, operational priorities, and capability investments essential for navigating the shifting parasiticides environment

In conclusion, the animal parasiticides sector is at an inflection point where scientific progress, shifting customer expectations, regulatory tightening, and trade-policy dynamics collectively redefine strategic priorities. Companies that combine differentiated therapeutic profiles with pragmatic stewardship, resilient sourcing strategies, and channel-aware commercialization models will be better positioned to capture sustainable value. The interplay between companion animal trends and livestock production needs creates both adjacent opportunities and operational complexities that require careful prioritization and investment.

Immediate attention to supplier diversification, integration of diagnostics and stewardship messaging, and tailored regional approaches will enable organizations to manage near-term volatility while building capabilities for longer-term differentiation. Ultimately, success will hinge on the ability to convert technical advantages into trusted, practical solutions that meet the real-world needs of veterinarians, pet owners, and livestock producers.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Parasiticides Market, by Animal Type

  • 8.1. Companion Animal
  • 8.2. Livestock

9. Animal Parasiticides Market, by Parasite Type

  • 9.1. External Parasite
  • 9.2. Internal Parasite

10. Animal Parasiticides Market, by Product Type

  • 10.1. Ectoparasiticides
    • 10.1.1. Flea And Tick Products
    • 10.1.2. Lice Products
    • 10.1.3. Mite Products
  • 10.2. Endoparasiticides
    • 10.2.1. Anthelmintics
    • 10.2.2. Antiprotozoals

11. Animal Parasiticides Market, by Route Of Administration

  • 11.1. Injectable
  • 11.2. Oral
  • 11.3. Topical

12. Animal Parasiticides Market, by Distribution Channel

  • 12.1. Online Pharmacies
  • 12.2. Pharmacies And Drug Stores
  • 12.3. Veterinary Hospitals And Clinics

13. Animal Parasiticides Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Animal Parasiticides Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Animal Parasiticides Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Animal Parasiticides Market

17. China Animal Parasiticides Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Bimeda Animal Health Ltd.
  • 18.6. Boehringer Ingelheim International GmbH
  • 18.7. Ceva S.A.
  • 18.8. Dechra Pharmaceuticals PLC
  • 18.9. Elanco Animal Health Incorporated
  • 18.10. Idexx Laboratories Inc.
  • 18.11. Merck & Co., Inc.
  • 18.12. PetIQ, Inc.
  • 18.13. Vetoquinol S.A.
  • 18.14. Virbac S.A.
  • 18.15. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL PARASITICIDES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANIMAL PARASITICIDES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ANIMAL PARASITICIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ANIMAL PARASITICIDES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY COMPANION ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY COMPANION ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY EXTERNAL PARASITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY EXTERNAL PARASITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY EXTERNAL PARASITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY INTERNAL PARASITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY INTERNAL PARASITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY INTERNAL PARASITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY FLEA AND TICK PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY FLEA AND TICK PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY FLEA AND TICK PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY LICE PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY LICE PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY LICE PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY MITE PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY MITE PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY MITE PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ANTHELMINTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ANTHELMINTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ANTHELMINTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ANTIPROTOZOALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ANTIPROTOZOALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ANTIPROTOZOALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS ANIMAL PARASITICIDES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS ANIMAL PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS ANIMAL PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS ANIMAL PARASITICIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS ANIMAL PARASITICIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ANIMAL PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA ANIMAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA ANIMAL PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA ANIMAL PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA ANIMAL PARASITICIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA ANIMAL PARASITICIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ANIMAL PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA ANIMAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA ANIMAL PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA ANIMAL PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA ANIMAL PARASITICIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ANIMAL PARASITICIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA ANIMAL PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE ANIMAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE ANIMAL PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE ANIMAL PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ANIMAL PARASITICIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE ANIMAL PARASITICIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ANIMAL PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST ANIMAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST ANIMAL PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST ANIMAL PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST ANIMAL PARASITICIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST ANIMAL PARASITICIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST ANIMAL PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA ANIMAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA ANIMAL PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA ANIMAL PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA ANIMAL PARASITICIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA ANIMAL PARASITICIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA ANIMAL PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ANIMAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ANIMAL PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ANIMAL PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ANIMAL PARASITICIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC ANIMAL PARASITICIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ANIMAL PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN ANIMAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN ANIMAL PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN ANIMAL PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN ANIMAL PARASITICIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ANIMAL PARASITICIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN ANIMAL PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. GCC ANIMAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GCC ANIMAL PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. GCC ANIMAL PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. GCC ANIMAL PARASITICIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 139. GCC ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 140. GCC ANIMAL PARASITICIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 141. GCC ANIMAL PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION ANIMAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION ANIMAL PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION ANIMAL PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION ANIMAL PARASITICIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION ANIMAL PARASITICIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ANIMAL PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS ANIMAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS ANIMAL PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS ANIMAL PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ANIMAL PARASITICIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS ANIMAL PARASITICIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS ANIMAL PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. G7 ANIMAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. G7 ANIMAL PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. G7 ANIMAL PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. G7 ANIMAL PARASITICIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 163. G7 ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 164. G7 ANIMAL PARASITICIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 165. G7 ANIMAL PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. NATO ANIMAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. NATO ANIMAL PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NATO ANIMAL PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO ANIMAL PARASITICIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. NATO ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 171. NATO ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 172. NATO ANIMAL PARASITICIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 173. NATO ANIMAL PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ANIMAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES ANIMAL PARASITICIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES ANIMAL PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES ANIMAL PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES ANIMAL PARASITICIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES ANIMAL PARASITICIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES ANIMAL PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA ANIMAL PARASITICIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA ANIMAL PARASITICIDES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA ANIMAL PARASITICIDES MARKET SIZE, BY PARASITE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA ANIMAL PARASITICIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA ANIMAL PARASITICIDES MARKET SIZE, BY ECTOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA ANIMAL PARASITICIDES MARKET SIZE, BY ENDOPARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA ANIMAL PARASITICIDES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA ANIMAL PARASITICIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)